Cambridge Healthtech Institute’s 6th Annual
Managing Outsourced Clinical Trials
Building Successful Partnerships with Effective Oversight, Risk Mitigation & Resource Management
February 20-21, 2020
As more clinical trial activities are outsourced to CROs and other third-party vendors, and as those CROs and vendors grow in their capabilities, it is more important than ever for sponsors and vendors to develop strong partnerships and establish themselves
as partners of choice. CHI’s 6th Annual Managing Outsourced Clinical Trials conference features case studies and lessons learned from sponsors and CROs on managing relationships, vendor quality and performance in light of the new ICH E6 R2 changes,
and how to build beneficial partnerships that effectively manage resources.
Arrive early and attend Part 1 (Wed - Thurs): Mastering an Outsourcing Strategy
Investigator Payments: A Critical Component in Realizing Your Sponsor of Choice Strategy
Geri Masessa, Senior Resource Manager, Clinical Operations, Bayer Healthcare
INTERACTIVE PANEL: Sponsor of Choice – Small Company, Different Needs, Same Desires
Moderator: Ly Kawaguchi, Senior Director, Head of Clinical Outsourcing, Site Budgets/CTAs, and Business
Analytics, Outsourcing and Procurement, MyoKardia
Panelists: Adrienne Robinson, Associate Director, Clinical Outsourcing, MyoKardia
White, Associate Director, Clinical Site Budgets/CTAs, Mxxxx
The Value of Supplier Relationship Management: CROs vs. Technology Outsourcing
Krista Emmons, Associate Director, Portfolio Relationship Management, R&D Procurement, Astellas Pharma
Managing Offshore Outsourcing of Clinical Trial Research
Minji Bae, Associate Director, Vendor Management, AbbVie
Defining Metrics for Quality Vendor Oversight
Keith Dorricott, Ambassador, Metrics Champion Consortium; Director, DMPI, Ltd.
INTERACTIVE PANEL: How Varying Resource Availability Affects Outsourcing, Operations, and Pressures in Large vs. Small Pharma
Moderator: Chuck Bradley, Vice President, Clinical Development, FibroGen, Inc.